MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...
MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...
This rewards program gets high marks from travelers for its relatively high potential point values and its flexible redemption options — including some top-notch transfer partners. Many or all of the ...
Students earn status by engaging in campus events, completing approved courses and participating in globally oriented experiences. Each status can be earned independently and repeated as students ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results